No doubt, the year 2022 has commenced on a remarkable note for Sovereign Trust Insurance Plc going by the first quarter unaudited account recently released by the underwriting company.
For Sovereign Trust Insurance Plc, things are actually looking up considering the Company’s first quarter performance in 2022 when compared to the same corresponding period in 2021.
The Total Gross Premium written in the first quarter of 2022 amounted to N7.35b while in 2021, the total Gross Premium written was put at N5.37b in the same period under review, giving a 37% growth rate over the performance of 2021.
Profit Before Tax grew by 19% in the first quarter of 2022 to the sum of N609m as against the sum of N510m in the same corresponding period of 2021, while Profit After Tax rose from N392m in the first quarter of 2021 to N489m in Q1 of 2022, with a growth rate of 25% respectively. The Total Equity also grew by 12% from N9b in the first quarter of 2021 to N10.1b in the same corresponding period of 2022.
Interestingly, as a result of the Company’s improved claims administration and processes backed by top-notch technology, the claims payout in the first quarter of 2022 stood at N946m as against the figure of N1.26b paid on claims in the same corresponding period of 2021, while the Net Claims Expense also reduced by 16% from N965m in the first quarter of 2021 to N808m in the first quarter of 2022.
Earnings per Share grew from 3.45kobo in Q1 of 2021 to 4.3kobo in the same corresponding period of 2022. The Net Assets per Share also grew from 79.4kobo in the first quarter of 2021 to 88.9kobo in Q1 of 2022.
Notwithstanding the harsh operating environment that has beclouded the operations of so many insurance companies and other corporate organizations in the first quarter of the year especially at a period when the country is preparing for another general election come 2023, Sovereign Trust Insurance Plc has been able to record meaningful appreciation in all its financial indices going by its first quarter unaudited financial statements.
The future indeed, looks very promising.
